Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Human EGFR (Research Grade Cetuximab Biosimilar) PE-conjugated Antibody, R&D Systems™
GREENER_CHOICE

Human Monoclonal Antibody

Supplier:  R&D Systems FAB9577P100

Catalog No. FAB9577P100


Only null left
Add to Cart
This item is not returnable. View return policy

Description

Description

EGFR Monoclonal specifically detects EGFR in Human samples. It is validated for Flow Cytometry.
Specifications

Specifications

EGFR
Monoclonal
R-PE
Supplied in a saline solution containing BSA and Sodium Azide.
Human
Protein A or G purified from cell culture supernatant
Primary
Detects human EGFR based on Cetuximab therapeutic antibody. This non-therapeutic antibody uses the same variable region sequence as the therapeutic antibody Cetuximab. This product is for research use only.
Protect from light. Do not freeze. 12 months from date of receipt, 2 to 8 degreesC as supplied.
IgG1
Flow Cytometry
Hu1
Flow Cytometry 10 uL/10^6 cells
avian erythroblastic leukemia viral (v-erb-b) oncogene homolog, cell growth inhibiting protein 40, cell proliferation-inducing protein 61, EC 2.7.10, EC 2.7.10.1, EGF R, epidermal growth factor receptor, epidermal growth factor receptor (avian erythroblastic leukemia viral (v-erb-b)oncogene homolog), ErbB, ErbB1, ERBB1PIG61, HER1, HER-1, mENA, Proto-oncogene c-ErbB-1, Receptor tyrosine-protein kinase erbB-1
Human EGF R/ErbB1
100 Tests
1956
Human
Supernatant
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.